Palo Santo raises $50 mln for largest-ever venture capital fund focused purely on psychedelic medicine
October 12, 2022 at 08:47 AM EDT
Venture capital fund Palo Santo is closing its oversubscribed debut fund with $50 million of commitments in what the two-year-old firm describes as the largest pure-play venture capital pool dedicated to developing FDA-approved psychedelic drugs, MarketWatch has learned.
